Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan

Japanese Journal of Infectious Diseases

Volumn 63, Issue 4, 2010, Pages 304-305

  Ikebe, Tadayoshi ^a   Wada, Akihito ^a   Oguro, Yuuko ^b   Ogata, Kikuyo ^c   Katsukawa, Chihiro ^d   Isobe, Junko ^e   Shima, Tomoko ^e   Suzuki, Rieko ^f   Ohya, Hitomi ^f   Tominaga, Kiyoshi ^g   Okuno, Rumi ^h   Uchitani, Yumi ^h   Watanabe, Haruo ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b Fukushima Institute of Public Health   (Japan)

^c Oita Prefectural Institute of Health and Environment   (Japan)

^d OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^e TOYAMA INSTITUTE OF HEALTH   (Japan)

^f KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^g Yamaguchi Prefectural Institute of Public Health and Environment   (Japan)

^h TOKYO METROPOLITAN INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CLINDAMYCIN; EXCISASE; INTEGRASE; RESOLVASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BACTERIAL DNA; TRANSPOSON;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISEASE SEVERITY; GROUP A STREPTOCOCCAL INFECTION; HUMAN; JAPAN; NONHUMAN; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; DRUG EFFECTS; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MICROBIOLOGY; STREPTOCOCCUS INFECTION; TRANSPOSON;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; GENOTYPE; HUMANS; JAPAN; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 77954983648     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Cunningham, M.W. (2000): Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev., 13, 470-511.
2. Bisno, A.L. and Stevens, D.L. (1996): Streptococcal infections of skin and soft tissues. N. Engl. J. Med., 334, 240-245.
3. Stevens, D.L., Gibbons, E.A., Bergstrom, R., et al. (1988): The eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J. Infect. Dis., 158, 23-28.
4. Ikebe, T., Murai, N., Endo, M., et al. (2003): Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan. Epidemiol. Infect., 130, 569-572.
5. Clinical and Laboratory Standards Institute. (2007): Performance standards for antimicrobial susceptibility testing, 15th edition. Approved standard M100-S17. Clinical and Laboratory Standards Institute, Wayne, Pa6.
6. Clewell, D.B., Flannagan, S.E. and Jaworski, D.D. (1995): Unconstrained bacterial promiscuity: the Tn916-Tnl545 family of conjugative transposons. Trends Microbiol., 3, 229-236.
7. Mullany, P., Wilks, M., Lamb, I., et al. (1990): Genetic analysis of a tetracycline resistance element from Clostridium difficile and its conjugal transfer to and from Bacillus subtilis. J. Gen. Microbiol., 136, 1343-1349.
8. Roberts, A.P., Johanesen, P.A., Lyras, D., et al. (2001): Comparison of Tn5397 from Clostridium difficile, Tn916 from En-terococcus faecalis and the CW459tet(M) element from Clostridium perfringens shows that they have similar conjugation regions but different insertion and excision modules. Microbiology, 147, 1243-1251.
9. Rice, L.B. (1998): Tn916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob. Agents Chemother., 42, 1871-1877.